 |
cabozantinib |
|---|---|
| Trade Name | Cometriq |
| Orphan Indication | Papillary thyroid cancer |
| USA Market Approval | USA |
| USA Designation Date | 2010-11-29 00:00:00 |
| Sponsor | Exelixis, Inc.;210 East Grand Avenue;South San Francisco, California, 94083 |
| |
cabozantinib |
|---|---|
| Trade Name | Cometriq |
| Orphan Indication | Papillary thyroid cancer |
| USA Market Approval | USA |
| USA Designation Date | 2010-11-29 00:00:00 |
| Sponsor | Exelixis, Inc.;210 East Grand Avenue;South San Francisco, California, 94083 |